BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15161930)

  • 1. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
    Greschik H; Flaig R; Renaud JP; Moras D
    J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
    Shiau AK; Barstad D; Loria PM; Cheng L; Kushner PJ; Agard DA; Greene GL
    Cell; 1998 Dec; 95(7):927-37. PubMed ID: 9875847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
    Wang L; Zuercher WJ; Consler TG; Lambert MH; Miller AB; Orband-Miller LA; McKee DD; Willson TM; Nolte RT
    J Biol Chem; 2006 Dec; 281(49):37773-81. PubMed ID: 16990259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
    Chakraborty S; Levenson AS; Biswas PK
    BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer.
    Gowda K; Marks BD; Zielinski TK; Ozers MS
    Anal Biochem; 2006 Oct; 357(1):105-15. PubMed ID: 16889744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3.
    Greschik H; Wurtz JM; Sanglier S; Bourguet W; van Dorsselaer A; Moras D; Renaud JP
    Mol Cell; 2002 Feb; 9(2):303-13. PubMed ID: 11864604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of bacterially expressed rat estrogen receptor beta ligand binding domain by mass spectrometry: structural comparison with estrogen receptor alpha.
    Witkowska HE; Carlquist M; Engström O; Carlsson B; Bonn T; Gustafsson JA; Shackleton CH
    Steroids; 1997; 62(8-9):621-31. PubMed ID: 9292936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.
    Liu H; Park WC; Bentrem DJ; McKian KP; Reyes Ade L; Loweth JA; Schafer JM; Zapf JW; Jordan VC
    J Biol Chem; 2002 Mar; 277(11):9189-98. PubMed ID: 11751902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism.
    Kallen J; Lattmann R; Beerli R; Blechschmidt A; Blommers MJ; Geiser M; Ottl J; Schlaeppi JM; Strauss A; Fournier B
    J Biol Chem; 2007 Aug; 282(32):23231-9. PubMed ID: 17556356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for transcriptional regulation by the orphan nuclear receptor ERRgamma.
    Huppunen J; Wohlfahrt G; Aarnisalo P
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):151-60. PubMed ID: 15149736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimerization modulates the activity of the orphan nuclear receptor ERRgamma.
    Huppunen J; Aarnisalo P
    Biochem Biophys Res Commun; 2004 Feb; 314(4):964-70. PubMed ID: 14751226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma.
    Matsushima A; Kakuta Y; Teramoto T; Koshiba T; Liu X; Okada H; Tokunaga T; Kawabata S; Kimura M; Shimohigashi Y
    J Biochem; 2007 Oct; 142(4):517-24. PubMed ID: 17761695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
    Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF
    J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary molecular dynamic simulations of the estrogen receptor alpha ligand binding domain from antagonist to apo.
    McGee TD; Edwards J; Roitberg AE
    Int J Environ Res Public Health; 2008 Jun; 5(2):111-4. PubMed ID: 18678925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activity of estrogen-related receptor γ (ERRγ) is stimulated by the phytoestrogen equol.
    Hirvonen J; Rajalin AM; Wohlfahrt G; Adlercreutz H; Wähälä K; Aarnisalo P
    J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):46-57. PubMed ID: 21056663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
    Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
    J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes.
    Liu S; Han SJ; Smith CL
    Mol Pharmacol; 2013 May; 83(5):1066-77. PubMed ID: 23462505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.
    Nose T; Tokunaga T; Shimohigashi Y
    Toxicol Lett; 2009 Dec; 191(1):33-9. PubMed ID: 19666091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
    Paech K; Webb P; Kuiper GG; Nilsson S; Gustafsson J; Kushner PJ; Scanlan TS
    Science; 1997 Sep; 277(5331):1508-10. PubMed ID: 9278514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.